Phase III randomized study of radiation and temozolomide versus radiation and nitrosourea therapy for anaplastic astrocytoma: results of NRG Oncology RTOG 9813-Reference-Cited by-同舟云学术

Phase III randomized study of radiation and temozolomide versus radiation and nitrosourea therapy for anaplastic astrocytoma: results of NRG Oncology RTOG 9813

Published:2016-12-18 Issue: Volume: Page:now236
ISSN:1522-8517
Container-title:Neuro-Oncology
language:en
Short-container-title:NEUONC

Author:

Chang Susan,Zhang Peixin,Cairncross J. Gregory,Gilbert Mark R.,Bahary Jean-Paul,Dolinskas Carol A.,Chakravarti Arnab,Aldape Kenneth D.,Bell Erica H.,Schiff David,Jaeckle Kurt,Brown Paul D.,Barger Geoffrey R.,Werner-Wasik Maria,Shih Helen,Brachman David,Penas-Prado Marta,Robins H. Ian,Belanger Karl,Schultz Christopher,Hunter Grant,Mehta Minesh

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Clinical Neurology,Oncology

Link

http://academic.oup.com/neuro-oncology/article-pdf/19/2/252/17682204/now236.pdf

Reference16 articles.

1. Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials

2. Randomized trial of procarbazine, lomustine, and vincristine in the adjuvant treatment of high-grade astrocytoma: a Medical Research Council trial;Medical Research Council Brain Tumor Working Party;J Clin Oncol,2001

3. Procarbazine, lomustine, and vincristine (PCV) chemotherapy for anaplastic astrocytoma: a retrospective review of radiation therapy oncology group protocols comparing survival with carmustine or PCV adjuvant chemotherapy;Prados;J Clin Oncol,1999

4. Multicentre CRC phase II trial of temozolomide in recurrent or progressive high-grade glioma

5. Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group;Yung;J Clin Oncol,1999

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Racial and social-economic inequalities in systemic chemotherapy use among adult glioblastoma patients following surgery and radiotherapy;Scientific Reports;2024-08-17

2. Multidisciplinary Management of Isocitrate Dehydrogenase–Mutated Gliomas in a Contemporary Molecularly Defined Era;Journal of Clinical Oncology;2024-07-20

3. The biological significance of tumor grade, age, enhancement, and extent of resection in IDH-mutant gliomas: How should they inform treatment decisions in the era of IDH inhibitors?;Neuro-Oncology;2024-06-24

4. Consensus guidelines for the management of adult low-grade gliomas for low and middle-income countries;J PAK MED ASSOC;2024

5. Updates on management of gliomas in the molecular age;World Journal of Clinical Oncology;2024-02-24